DWTX Dogwood Therapeutics, Inc.

NASDAQ
$1.06

Dogwood Therapeutics, Inc. (DWTX) is expected to report earnings on February 4, 2027, before the market open. The consensus earnings estimate is a loss of $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.0% since its last earnings release on November 5, 2026.

Dogwood Therapeutics, Inc. Beat Consensus Estimates
Thursday, November 5, 2026 · 8:30 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 8:30 AM ET
Earnings Whisper
-
vs ($0.16)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.14

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Dogwood Therapeutics, Inc.

Dogwood Therapeutics is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathic disorders.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.